Our Focus on Ophthalmology
At Surrozen, we are pioneering therapies that harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. Our therapeutics are designed to restore and repair ocular tissues by addressing the underlying drivers of disease. Our mission is to help patients preserve and regain the ability to see the people and moments that matter most.
Our pipeline addresses some of the most pressing unmet needs in ocular diseases
Diabetic macular edema
Wet age-related macular degeneration
Uveitic macular edema
Our pipeline addresses some of the most pressing unmet needs in ocular diseases
Diabetic macular edema
Wet age-related macular degeneration
Diabetic macular edema
Management Team
Board of Directors
Chairman of the Board
Chief Executive Officer
Chief Scientific Officer, Pancreatic Cancer Action Network
Venture Partner, SR One Capital Management
Independent Board Member
Independent Board Member
Independent Board Member
CFO, Mirum Pharmaceuticals, Inc.
Managing Partner, The Column Group, LLC
Scientific Advisors
Professor of Molecular and Cellular Physiology and Structural Biology
Maureen Lyles D’Ambrogio Professor of Medicine and Professor of Chemical and Systems Biology
Virginia and Daniel K. Ludwig Professor of Cancer Research and Professor of Developmental Biology
Lewis Thomas University Professor of Medicine